Litcius/Paper detail

Coronaviruses Use ACE2 Monomers as Entry‐Receptors

Patrick Eiring, Teresa Klein, Simone Backes, Marcel Streit, Marvin Jungblut, Sören Doose, Gerti Beliu, Markus Sauer

2023Angewandte Chemie International Edition19 citationsDOIOpen Access PDF

Abstract

Abstract The angiotensin‐converting enzyme 2 (ACE2) has been identified as entry receptor on cells enabling binding and infection with the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) via trimeric spike (S) proteins protruding from the viral surface. It has been suggested that trimeric S proteins preferably bind to plasma membrane areas with high concentrations of possibly multimeric ACE2 receptors to achieve a higher binding and infection efficiency. Here we used direct stochastic optical reconstruction microscopy ( d STORM) in combination with different labeling approaches to visualize the distribution and quantify the expression of ACE2 on different cells. Our results reveal that endogenous ACE2 receptors are present as monomers in the plasma membrane with densities of only 1–2 receptors μm −2 . In addition, binding of trimeric S proteins does not induce the formation of ACE2 oligomers in the plasma membrane. Supported by infection studies using vesicular stomatitis virus (VSV) particles bearing S proteins our data demonstrate that a single S protein interaction per virus particle with a monomeric ACE2 receptor is sufficient for infection, which provides SARS‐CoV‐2 a high infectivity.

Topics & Concepts

ReceptorViral entryInfectivityCoronavirusVesicular stomatitis virusCell biologyBiologyVirologyVirusBiophysicsChemistryBiochemistryCoronavirus disease 2019 (COVID-19)Viral replicationMedicineInfectious disease (medical specialty)DiseasePathologySARS-CoV-2 and COVID-19 ResearchLipid Membrane Structure and BehaviorCOVID-19 Clinical Research Studies